-
Baneyx F, Mujacic M, 2004: Recombinant protein folding and misfolding in Escherichia coli[J]. Nat Biotechnol, 22, 1399-1408. doi: 10.1038/nbt1029
-
Buchner J, Pastan I, Brinkmann U, 1992: A method for increasing the yield of properly folded recombinant fusion proteins: single-chain immunotoxins from renaturation of bacterial inclusion bodies[J]. Anal Biochem, 205, 263-270. doi: 10.1016/0003-2697(92)90433-8
-
Choi J H, Lee S Y, 2004: Secretory and extracellular production of recombinant proteins using Escherichia coli[J]. Appl Microbiol Biotechnol, 64, 625-635. doi: 10.1007/s00253-004-1559-9
-
Choi N W, Estes M K, Langridge W H R, 2005: Oral immunization with a shiga toxin B subunit: Rotavirus NSP4(90) fusion protein protects mice against gastroenteritis[J]. Vaccine, 23, 5168-5176. doi: 10.1016/j.vaccine.2005.06.015
-
Goncalves A N, Meschiari C A, Stetler-Stevenson W G, Nonato M C, Alves C P, Espreafico E M, Gerlach R F, 2012: Expression of soluble and functional full-length human Matrix Metalloproteinase-2 in Escherichia coli[J]. J Biotechnol, 157, 20-24. doi: 10.1016/j.jbiotec.2011.09.030
-
Haicheur N, Bismuth E, Bosset S, Adotevi O, Warnier G, Lacabanne V, Regnault A, Desaymard C, Amigorena S, Ricciardi-Castagnoli P, 2000: The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class Ⅰ-restricted presentation of peptides derived from exogenous antigens[J]. J Immunol, 165, 3301-3309. doi: 10.4049/jimmunol.165.6.3301
-
Haicheur N, Benchetrit F, Amessou M, Leclerc C, Falguires T, Fayolle C, Bismuth E, Fridman W H, Johannes L, Tartour E, 2003: The B subunit of Shiga toxin coupled to full-size antigenic protein elicits humoral and cell-mediated immune responses associated with a Th1 dominant polarization[J]. Int immunol, 15, 1161-1171. doi: 10.1093/intimm/dxg118
-
Han L, Doverskog M, Enfors S O, Häggström L, 2002: Effect of glycine on the cell yield and growth rate of Escherichia coli: evidence for cell-density-dependent glycine degradation as determined by 13C NMR spectroscopy[J]. J Biotechnol, 92, 237-249. doi: 10.1016/S0168-1656(01)00373-X
-
Humphreys D P, Sehdev M, Chapman A P, Ganesh R, Smith B J, King L M, Glover D J, Reeks D G, Stephens P E, 2000: High-level periplasmic expression in Escherichia coli using a eukaryotic signal peptide: importance of codon usage at the 5'end of the coding sequence[J]. Protein Expr Purif, 20, 252-264. doi: 10.1006/prep.2000.1286
-
Janssen K P, Vignjevic D, Boisgard R, Falguires T, Bousquet G, Decaudin D, Dolli F, Louvard D, Tavitian B, Robine S, 2006: In vivo tumor targeting using a novel intestinal pathogen-based delivery approach[J]. Cancer Res, 66, 7230-7237. doi: 10.1158/0008-5472.CAN-06-0631
-
LaCasse E C, Saleh M T, Patterson B, Minden M D, Gariepy J, 1996: Shiga-like toxin purges human lymphoma from bone marrow of severe combined immunodeficient mice[J]. Blood, 88, 1561-1567.
-
Lee R S, Tartour E, Van der Bruggen P, Vantomme V, Joyeux I, Goud B, Fridman W H, Johannes L, 1998: Major histocompatibility complex class Ⅰ presentation of exogenous soluble tumor antigen fused to the B-fragment of Shiga toxin[J]. Eur J Immunol, 28, 2726-2737. doi: 10.1002/(ISSN)1521-4141
-
Li J, Liu J, Lan X, Cheng J, Wu R, Lou Z Z, Yin X, Li X, Li B, Yang B, 2009: Cloning the structure genes and expression the N gene of porcine epidemic diarrhea virus DX[J]. Virol Sin, 24, 179-186. doi: 10.1007/s12250-009-2982-y
-
Li Y L, Liu J, Liu J N, Zhang J, 2011: Immunization of protein HPV16 E7 in fusion with mouse HSP70 inhibits the growth of TC-1 cells in tumor bearing mice[J]. Vaccine, 29, 5959-5962. doi: 10.1016/j.vaccine.2011.06.046
-
Nakagawa I, Nakata M, Kawabata S, Hamada S, 1999: Regulated expression of the Shiga toxin B gene induces apoptosis in mammalian fibroblastic cells[J]. Mol Microbiol, 33, 1190-1199.
-
Ni Y, Chen R, 2009: Extracellular recombinant protein production from Escherichia coli[J]. Biotechnol Lett, 31, 1661-1670. doi: 10.1007/s10529-009-0077-3
-
O'Brien A D, Tesh V L, Donohue-Rolfe A, Jackson M P, Olsnes S, Sandvig K, Lindberg A A, Keusch G T, 1992: Shiga toxin: biochemistry, genetics, mode of action and role in pathogenesis[J]. Curr Top Microbiol Immunol, 180, 65-94.
-
Ohmura M, Yamamoto M, Tomiyama-Miyaji C, Yuki Y, Takeda Y, Kiyono H, 2005: Nontoxic Shiga toxin derivatives from Escherichia coli possess adjuvant activity for the augmentation of antigen-specific immune responses via dendritic cell activation[J]. Infect Immu, 73, 4088-4097. doi: 10.1128/IAI.73.7.4088-4097.2005
-
Sadraeian M, Honari H, Madanchi H, Hesaraki M, 2011: Cloning and Expression of CtxB-StxB in Esherichia coli: A challenge for Improvement of Immune Response Against StxB[J]. Iran J Pharm Sci, 7, 185-190.
-
Sedighzadeh S S, Shamsara M and Shahpiri A. 2012. Fusion Protein Strategy to Increase Expression and Solubility of Hypervariable Region of VP2 Protein of Infectious Bursal Disease Virus in Escherichia coli. Prot J: 1-5.
-
Shaw C A, Starnbach M N, 2003: Using modified bacterial toxins to deliver vaccine antigens[J]. ASM News, 69, 384-389.
-
Vingert B, Adotevi O, Patin D, Jung S, Shrikant P, Freyburger L, Eppolito C, Sapoznikov A, Amessou M, Quintin-Colonna F, 2006: The Shiga toxin B-subunit targets antigen in vivo to dendritic cells and elicits anti-tumor immunity[J]. Eur J Immunol, 36, 1124-1135. doi: 10.1002/(ISSN)1521-4141
-
Wang P, Song P, Li X, Su R R, Wang H, Zhu G P, 2012: Study on soluble e xpression of g lutamate d ehydrogenase from t ea p lant in Escherichia coli using fusion tags[J]. African J Biotechnol, 11, 6241-6250.
-
Weikert C, Sauer U, Bailey J E, 1998: An Escherichia coli host strain useful for efficient overproduction of secreted recombinant protein[J]. Biotechnol Bioeng, 59, 386-391. doi: 10.1002/(ISSN)1097-0290
-
Yang J, Moyana T, MacKenzie S, Xia Q, Xiang J, 1998: One Hundred Seventy-Fold Increase in Excretion of an FV Fragment-Tumor Necrosis Factor Alpha Fusion Protein (sFV/TNF-α) from Escherichia coli Caused by the Synergistic Effects of Glycine and Triton X-100[J]. Appl Environ Microbiol, 64, 2869-2874.
-
Zhang S, Fan R, Yang T, Sun Y, Li J, Xu Q, Zhou P, 2009: An improved strategy for efficient expression and purification of soluble HIV-1 tat protein in E. coli.[J]. Virol Sin, 24, 518-528. doi: 10.1007/s12250-009-3068-6